The question of whether it is safe to take cannot yet be definitively answered and until full Phase 3 data are available and regulatory approval is granted, the safest course of action is to pursue treatment through established, approved pathways under the guidance of a qualified healthcare professional
Which medications fall under each option
Brandon Richland, MD Tirzepatide is a relatively new medication that has shown promise in the management of type 2 diabetes and weight loss
The drug can play two functions: (1) maintain a healthy glucose level in the body
Weight Loss: In phase III trials, weight loss with the use of exenatide averaged between 0.9 and 2.8 kg over a 30-month time frame, with more weight loss associated when exenatide is added to existing metformin therapy
Olde Damink SW, Deutz NE, Dejong CH, et al